FDA accepts Vertex’s new drug application for combination treatment
The FDA acceptance is based on the previously announced positive results of two global Phase 3 studies in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
21 Aug 19
The FDA acceptance is based on the previously announced positive results of two global Phase 3 studies in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 Aug 19
DAPA-HF marks the first trial on heart failure outcomes with an SGLT2 inhibitor in patients with and without…
18 Jul 19
A powerful bee sting vaccine designed to eliminate the risk of a severe allergic reaction to European honeybee…
17 Jul 19
Researchers at Boston Children's Hospital have created the first human tissue model of an inherited heart arrhythmia, replicating…
03 Jul 19
If you think training is expensive, try ignorance. In this white paper Martin Lush highlights the effectiveness of…
03 Jul 19
John Johnson discusses the risks associated with global supply chains and suggests a defined outsourcing management process to…
01 Jul 19
For years, researchers have been attempting to target a gene called MYC that is known to drive tumour…
25 Jun 19
Statins are one of the most widely prescribed medications but there is ongoing concern they are associated with…
25 Jun 19
Chronic diseases, such as hypertension and rheumatoid arthritis are persistent conditions, which require lifelong management